https://www.selleckchem.com/products/nx-1607.html
Study assessments will take place at baseline, 6weeks, 6, 12, 18 and 24months. The primary effectiveness outcome is medication adherence via pill count, secondary outcomes include self-reported adherence and clinical outcomes. Process outcomes and cost-effectiveness will also be examined. The TAKE IT trial presents an innovative approach to monitoring and optimizing medication adherence among a population taking complex medication regimens. This trial seeks to evaluate the effectiveness and feasibility of this strategy compared to usual
Like
Comment
Share
